Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 23213099)

1.

Achieving the best of both worlds.

Ko AH, Cella D.

J Clin Oncol. 2013 Jan 1;31(1):3-4. doi: 10.1200/JCO.2012.46.4891. Epub 2012 Dec 3. No abstract available.

2.

Second-line therapy in gemcitabine-pretreated patients with advanced pancreatic cancer.

Boeck S, Heinemann V.

J Clin Oncol. 2008 Mar 1;26(7):1178-9; author reply 1179. doi: 10.1200/JCO.2007.15.3304. No abstract available.

3.

Evolving panorama of treatment for metastatic pancreas adenocarcinoma.

O'Reilly EM.

J Clin Oncol. 2013 May 1;31(13):1621-3. doi: 10.1200/JCO.2013.48.7660. Epub 2013 Apr 1. No abstract available.

4.

[How I treat ... An advanced pancreatic cancer].

Polus M, Jerusalem G, Sautois B, Silvestre RM, Fillet G.

Rev Med Liege. 2002 Mar;57(3):131-4. Review. French.

PMID:
12014258
5.

Palliative chemotherapy for pancreatic malignancies.

Mehta SP.

Surg Clin North Am. 2010 Apr;90(2):365-75. doi: 10.1016/j.suc.2009.12.005. Review.

PMID:
20362792
6.

Clinical update of gemcitabine in pancreas cancer.

Au E.

Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:469-73. Review.

PMID:
10895197
7.

[Chemoradiation for pancreatic adenocarcinoma].

Flandin I, Mornex F, Claude L, Kubas A, Khodri M, Wautot V, Mazeron R, Partensky C.

Cancer Radiother. 2004 Nov;8 Suppl 1:S80-7. Review. French.

PMID:
15679252
8.

[Gemzar (gemcitabine)--a new chemotherapeutic agent for pancreatic cancer].

Merimsky O, Chaitchik S.

Harefuah. 1997 Sep;133(5-6):208-12. Review. Hebrew. No abstract available.

PMID:
9461693
9.

[Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer].

Ohkawa S.

Nihon Rinsho. 2006 Jan;64 Suppl 1:198-202. Review. Japanese. No abstract available.

PMID:
16457249
10.

Treatment of metastatic pancreatic adenocarcinoma: a comprehensive review.

Kozuch P, Petryk M, Evans A, Bruckner HW.

Surg Clin North Am. 2001 Jun;81(3):683-90. Review.

PMID:
11459281
11.

Treatment of metastatic pancreatic cancer.

Ko AH, Tempero MA.

J Natl Compr Canc Netw. 2005 Sep;3(5):627-36. Review.

PMID:
16194454
12.

Locally advanced pancreatic cancer: where should we go from here?

Philip PA.

J Clin Oncol. 2011 Nov 1;29(31):4066-8. doi: 10.1200/JCO.2011.37.2532. Epub 2011 Oct 3. No abstract available.

13.

Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.

Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Boige V, Bérille J, Conroy T.

J Clin Oncol. 2013 Jan 1;31(1):23-9. doi: 10.1200/JCO.2012.44.4869. Epub 2012 Dec 3.

14.

[Gemcitabine treatment of pancreatic cancer peritonitis].

Horiki N, Maruyama M, Fujita Y, Suzuki Y, Tanaka T, Shimomura M, Tanigawa K, Sasaki H, Fujiwara M, Suzuki K, Imoto I, Adachi Y.

Nihon Shokakibyo Gakkai Zasshi. 2003 Jan;100(1):73-8. Review. Japanese. No abstract available.

PMID:
12601933
15.

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M.

Chemotherapy. 2004 Jun;50(3):127-32.

PMID:
15282439
16.

Gemcitabine: a ray of hope for pancreatic cancer?

Gupta P.

Natl Med J India. 1997 Mar-Apr;10(2):72-3. No abstract available.

PMID:
9153984
17.

Combined gemcitabine and alpha-interferon therapy for pancreatic cancer: report of a case.

Sawai H, Okada Y, Tanaka M, Funahashi H, Yamamoto M, Takeyama H, Manabe T.

Dig Dis Sci. 2006 Jul;51(7):1285-9. No abstract available.

PMID:
16944027
18.

Capecitabine in carcinoma of the pancreas.

Smith DB, Neoptolemos JP.

Expert Opin Pharmacother. 2006 Aug;7(12):1633-9. Review.

PMID:
16872266
19.

Pancreatic cancer.

[No authors listed]

Clin Evid. 2003 Jun;(9):528-33. Review. No abstract available. Update in: Clin Evid. 2004 Jun;(11):626-32.

PMID:
12967377
20.

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup.

N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk